ArticleInternational journal of legal medicine2026
Retrospective analysis-based prioritization and degradation pattern characterization of sudden unexplained death susceptibility genes.
Article in International journal of legal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Molecular mechanisms of sudden unexplained death and recent updates on molecular autopsy strategies for forensic investigation.International journal of legal medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Genetic factors are known to have important roles in sudden unexplained death (SUD) of apparently healthy individuals. Currently, molecular autopsy is considered an effective diagnostic tool in the multidisciplinary management of SUD. Recent studies highlighted the contribution of regulatory variants to complex genetic disorders. Pathogenic variants within the untranslated regions of SUD susceptibility genes were also identified in certain cases. However, the functional validation of pathogenic variants outside of the coding regions remains challenging. As the most direct method, transcriptome analysis could be performed at the same time with molecular autopsy to identify the abnormal expression of SUD susceptibility genes, while the post-mortem degradation of mRNA in myocardial tissues has made it difficult to interpret the transcriptome profiling results. In this study, we performed a retrospective analysis-based prioritization of SUD susceptibility genes based on the distribution of pathogenic genetic variants in previous studies with molecular autopsy findings reported. After gene prioritization, we analyzed the transcriptome data of 432 left ventricle tissues with different sampling time intervals from the Genotype-Tissue Expression database, in order to characterize the degradation pattern of prioritized SUD susceptibility genes. Furthermore, RNA degradation difference between unfrozen and thawed samples was investigated. We demonstrated that with proper segmentation of genes according to their degradation patterns, a partial least squares-discriminant analysis could effectively recognize the expression difference of targeted genes between normal samples and simulated SUD cases. Taken together, our findings presented a strategy for the interpretation of RNA profiling results during the forensic investigation of SUD.
Indexed as
Identifiers
40956437What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.